ARCHIVES

DCT Board Approves Drug Development Recompetition

This article is from The Cancer Letter archive.

Vol. 16 No. 46 | November 30, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

NCI to Implement Plan For Stepped Up Patient Accrual Despite Reservations OF Group Chairmen

December 4, 1987

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

Eight Firms Join AACR As Sustaining Members

April 25, 1997

Radiology Program Has Accredited 1,200 Facilities

May 18, 1990

Research Suggestions Considered By DCBD Diagnostic Group

July 11, 1980